Adrian Rawcliffe Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Adrian Rawcliffe.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Adrian Rawcliffe. Adrian Rawcliffe is CEO and CFO in Adaptimmune Therapeutics PLC ($ADAP) and Chief Executive Officer in Adaptimmune Therapeutics PLC ($ADAP) and Chief Financial Officer in Adaptimmune Therapeutics PLC ($ADAP) and Director in Wave Life Sciences Ltd. ($WVE).
Latest Insider Trading Transactions of Adrian Rawcliffe
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 28 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 4.37 | 2,794 | 12,210 | 3,058 | 5.9 K to 3.1 K (-47.74 %) |
Jan 19 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 5.67 | 9,879 | 56,009 | 13,529 | 23.4 K to 13.5 K (-42.20 %) |
Jan 12 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 6.15 | 2,707 | 16,654 | 3,695 | 6.4 K to 3.7 K (-42.28 %) |
Jan 11 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Option Exercise | A | 0.00 | 728,160 | 1,019 | 728,160 | |
Jan 11 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Option Exercise | A | 1.03 | 3,260,400 | 3,358,212 | 3,260,400 | |
Jan 05 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 5.33 | 4,967 | 26,464 | 6,737 | 11.7 K to 6.7 K (-42.44 %) |
Sep 02 2020 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 8.51 | 2,776 | 23,637 | 3,076 | 5.9 K to 3.1 K (-47.44 %) |
Aug 20 2020 | WVE | Wave Life Sciences ... | Rawcliffe Adrian | Director | Option Exercise | A | 9.13 | 10,500 | 95,865 | 10,500 | |
Aug 04 2020 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 9.25 | 2,788 | 25,789 | 3,064 | 5.9 K to 3.1 K (-47.64 %) |
Jan 17 2020 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Option Exercise | A | 0.00 | 561,792 | 730 | 561,792 | |
Jan 17 2020 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Option Exercise | A | 0.74 | 2,515,536 | 1,861,497 | 2,515,536 | |
Jan 15 2020 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 5.13 | 3,236 | 16,616 | 3,166 | 6.4 K to 3.2 K (-50.55 %) |
Jan 07 2020 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 1.20 | 5,900 | 7,080 | 5,804 | 11.7 K to 5.8 K (-50.41 %) |
Sep 03 2019 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | CEO and CFO | Option Exercise | A | 0.00 | 140,448 | 169 | 140,448 | |
Sep 03 2019 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | CEO and CFO | Option Exercise | A | 0.00 | 140,448 | 169 | 140,448 | |
Sep 03 2019 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | CEO and CFO | Option Exercise | A | 0.27 | 628,872 | 169,795 | 628,872 | |
Sep 03 2019 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | CEO and CFO | Option Exercise | A | 0.27 | 628,872 | 169,795 | 628,872 | |
Aug 16 2019 | WVE | Wave Life Sciences ... | Rawcliffe Adrian | Director | Option Exercise | A | 20.34 | 10,500 | 213,570 | 10,500 | |
Aug 16 2019 | WVE | Wave Life Sciences ... | Rawcliffe Adrian | Director | Option Exercise | A | 20.34 | 10,500 | 213,570 | 10,500 | |
Jun 27 2019 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Financial Off ... | Option Exercise | A | 0.00 | 140,448 | 183 | 140,448 | |
Jun 27 2019 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Financial Off ... | Option Exercise | A | 0.68 | 628,872 | 427,633 | 628,872 | |
Jan 16 2019 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Financial Off ... | Sell | S | 5.37 | 3,084 | 16,559 | 3,318 | 6.4 K to 3.3 K (-48.17 %) |
Jan 08 2019 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Financial Off ... | Option Exercise | A | 0.00 | 280,896 | 365 | 280,896 | |
Jan 08 2019 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Financial Off ... | Option Exercise | A | 0.00 | 280,896 | 365 | 280,896 | |
Jan 08 2019 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Financial Off ... | Option Exercise | A | 0.89 | 1,257,744 | 1,119,392 | 1,257,744 | |
Jan 08 2019 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Financial Off ... | Option Exercise | A | 0.89 | 1,257,744 | 1,119,392 | 1,257,744 | |
Aug 15 2018 | WVE | Wave Life Sciences ... | Rawcliffe Adrian | Director | Option Exercise | A | 46.70 | 9,000 | 420,300 | 9,000 | |
Mar 22 2018 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Financial Off ... | Sell | S | 1.71 | 600,000 | 1,026,000 | 0 | 600 K to 0 (-100.00 %) |
Jan 17 2018 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Financial Off ... | Option Exercise | A | 0.00 | 153,648 | 215 | 153,648 | |
Jan 17 2018 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Financial Off ... | Option Exercise | A | 1.30 | 687,984 | 894,379 | 687,984 | |
Aug 17 2017 | WVE | Wave Life Sciences ... | Rawcliffe Adrian | Director | Option Exercise | A | 18.10 | 9,000 | 162,900 | 9,000 | |
Feb 01 2017 | WVE | Wave Life Sciences ... | Rawcliffe Adrian | Director | Option Exercise | A | 28.80 | 18,000 | 518,400 | 18,000 | |
Jan 18 2017 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Financial Off ... | Option Exercise | A | 0.72 | 2,072,976 | 1,492,543 | 2,072,976 | |
Jan 20 2016 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Financial Off ... | Option Exercise | A | 1.27 | 939,948 | 1,195,332 | 939,948 |
Page: 1